🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting products of uncertain source.

Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Response and Content Removal

According to the social media company, the service has taken down problematic material and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Details and Costs

Within these groups, messages display dark colored packages with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.